Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

AstraZeneca's Imfinzi Combo Cuts Death Risk 42% in Phase III VOLGA Trial – Landmark Perioperative Win in Muscle-Invasive Bladder Cancer
CompanyDrug

AstraZeneca’s Imfinzi Combo Cuts Death Risk 42% in Phase III VOLGA Trial – Landmark Perioperative Win in Muscle-Invasive Bladder Cancer

AstraZeneca plc (NYSE: AZN) presented high-level results from a prespecified interim analysis of the Phase III VOLGA clinical trial at the 2026 European Society for Medical Oncology (ESMO) Congress, showing…

InnoCare Pharma Q3 Revenue Surges 150.6% as Orelabrutinib Expansion Drives Turnaround to Profitability

InnoCare Pharma Q3 Revenue Surges 150.6% as Orelabrutinib Expansion Drives Turnaround to Profitability

Novartis Raises Full-Year Core Profit Guidance as Q3 Sales Grow 4% – Kisqali Surges 37% to Lead Priority Brands

Novartis Raises Full-Year Core Profit Guidance as Q3 Sales Grow 4% – Kisqali Surges 37% to Lead Priority Brands

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Sino Biopharmaceutical's TQB2101 Receives NMPA Approval for Phase I Trial in Advanced Malignancies
CompanyDrug

Sino Biopharmaceutical’s TQB2101 Receives NMPA Approval for Phase I Trial in Advanced Malignancies

Hengrui Pharmaceuticals Gains NMPA Approval for HRS-6719 in Solid Tumors
CompanyDrug

Hengrui Pharmaceuticals Gains NMPA Approval for HRS-6719 in Solid Tumors

Sunshine Guojian's SSGJ-627 Gains NMPA Approval for Ulcerative Colitis Trial
CompanyDrug

Sunshine Guojian’s SSGJ-627 Gains NMPA Approval for Ulcerative Colitis Trial

Bayer's Vividion Therapeutics Starts Phase I Study for RAS-PI3Kα Inhibitor
CompanyDrug

Bayer’s Vividion Therapeutics Starts Phase I Study for RAS-PI3Kα Inhibitor

Mabwell Bioscience's 7MW3711 ADC Receives Clinical Trial Approval in China
CompanyDrug

Mabwell Bioscience’s 7MW3711 ADC Receives Clinical Trial Approval in China

Guojian Qingke Biomedical Gains NMPA Approval for 3D MSCs in Stroke Trials
CompanyDrug

Guojian Qingke Biomedical Gains NMPA Approval for 3D MSCs in Stroke Trials

Zhifei Bio's Trivalent Influenza Vaccine Approved for Clinical Trials in China
CompanyDrug

Zhifei Bio’s Trivalent Influenza Vaccine Approved for Clinical Trials in China

Hengrui Pharmaceuticals Secures Clinical Trial Approval for HRS-9813 in IPF
CompanyDrug

Hengrui Pharmaceuticals Secures Clinical Trial Approval for HRS-9813 in IPF

Show More